Universal Biosecurity Limited is commercialising Fume8, a low-toxicity, residue-free fumigant already treating over 200 sea containers per month. Strategic partnerships with RISQ WA and collaborations via Murdoch University are helping UBL capture value across the fumigation supply chain while advancing regulatory approval. With patented technology positioned to replace traditional chemicals, UBL offers early-stage exposure to the multi-billion-dollar global fumigation market.
Universal Biosecurity Limited
UBL4
Lead Manager
Contact - Bryant Mclarty
0411 222 927
bmclarty@liquidity.com.au
Minimum Investment
A$2,000
Offer Details
Issue Price (Per Share)
A$0.0900
Minimum Subscription (before costs)
Offer Size
A$100,000
Shares Available
1,111,111
Maximum Subscription (before costs)
Offer Size
A$1,000,000
Shares Available
11,111,111
Documents & Downloads
Company Overview
Universal Biosecurity Limited is an Australian biotech company developing and commercialising Fume8, a low-toxicity, residue-free fumigation solution. The company addresses the growing global demand for safer, environmentally-friendly alternatives to traditional chemical fumigants used in agriculture, shipping, and storage.
With strategic partnerships with RISQ WA and collaborations via Murdoch University, UBL is advancing regulatory approval, expanding commercial adoption, and positioning its patented technology to disrupt the multi-billion-dollar fumigation market.
Fume8 Technology
Onsite nitrogen generator or bottles combine with liquid ethyl formate.
Fume8 precisely heats and injects nitrogen gas into a stream of liquid ethyl formate through the electronically controlled mixing chamber.
Inert nitrogen gas acts as a carrying gas to overcome the flammability of ethyl formate.
Fume8’s nitrogen and ethyl formate fumigant mix produces a safe, cost effective, fast acting and environmentally friendly gas fumigant.
Advantages
Logistically Efficient & Saves time:
- Ethyl Bromide requires a large exclusion zone. FUME8 venting is significantly faster – does not require sealed aeration. Exposure times of 3 to 12 hours versus days for phosphine
Breaks Down Naturally:
- Ethyl formate breaks down into naturally-occurring products – formic acid (food additive) and ethanol
Safe/Non Toxic:
- FDA classification – generally recognised as safe – Reduced OH&S Risks
Environmentally sustainable:
Fume8 has a zero Global Warming Potential (GWP) score compared to traditional fumigant Sulfuryl Flouride which has a GWP score of 4.8K
Indicative Use of Funds
Use of Funds
1.
Patent Protection and Intellectual Property
2.
Regulatory Approval
3.
Commercialisation and Operational Activities
4.
Research Collaboration
5.
Ongoing Operations and Business Continuity
Board & Management
Tom Puddy
CEO
Tom has 27 years of corporate Australian agricultural and food industry imports and exports experience and has held previous senior positions at Harvest Road Group, Co-Operative Bulk Handling and The Craig Mostyn Group. He was responsible for the development of the Craig Mostyn Groups containerised grain & hay exporting business. Tom’s wheat export marketing strategy work positioned CBH as the largest Australian exporter with USD$4.19 billion revenue in 2019. He created the investment strategy and project delivery for Blue Lake Milling - Australia’s largest oat milling and food processing business which was acquired by CBH and delivered, a modern oat milling plant in Western Australia from concept design to production ramp up and a renewable energy power plant feasibility to commercial contract award. He boasts a strong track record in the delivery of growth strategies, international trade marketing and commercial negotiation and has an extensive Australian and International network to help UBL fast track its commercial services and distribution.
Bryant Mclarty
Executive Director
Bryant is Australian Financial Services Licensee with over 25 years’ experience in Equity Capital Markets. He is an experienced chairman, executive and non-executive director and founder of many successful private and Australian Stock Exchange listed companies. He is currently the chairman of Mac Equity Partners and Petrex Australia, SeaStock and Liquidity and is an Executive Director of Universal Biosecurity.
Simon Andrew
Non-Executive Director
Simon has 20 years’ experience in financial markets in Asia and Australia and has worked in various roles. Founding director of an ASX listed company Emmerson Resources Limited, with an additional eight years as a non-executive director. Previously Head of Business Development for ASX listed Yowie Group, a role that required a significant amount of effort in developing offshore markets.
Disclaimer
This site does not constitute an offer, recommendation, or invitation to any person, nor does it purport to provide all of the information an interested party may require in order to investigate the affairs of Universal Biosecurity Limited. This site is provided for information only and has not been prepared with the intention that the recipient should rely on it. Liquidity Technology Pty Ltd ("Liquidity") does not make any representation in relation to the contents of this site or give any assurances as to the accuracy or the degree of care or diligence used in preparing this document. The information, data, and advice herein is provided to recipients on the clear understanding that Liquidity nor any of its representatives, directors, officers, employees, agents, or advisers makes any representation or warranty about its accuracy, reliability, completeness, or suitability for any particular purpose and does not accept liability (including, but not limited to, for any expenses, losses, damages, and/or costs (including, but not limited to, indirect or consequential damage)) nor take any responsibility of any kind whatsoever (including, but not limited to, whether in contract, tort, financial or otherwise) for the information, data, or advice contained in or for any omission or for any other information, statement, or representation provided to any recipient (including, but not limited to, as a result of information, data, or advice being inaccurate, unreliable, incomplete, or unsuitable in any way and for any reason whatsoever). Users of this site must conduct their own investigation and analysis regarding any information, statement, or representation contained or provided to any recipient or its associates by Liquidity or any of the Liquidity Personnel. Each recipient waives any right of action, which it has now or in the future against Liquidity or any of the Liquidity Personnel in respect of any errors or omissions on or from this site, however caused. All rights are reserved. If the whole or any part of a provision of this "Notice and Disclaimer" is invalid, illegal, or unenforceable, then such provision will be severed and neither that part or provision or its severance will affect the validity or enforceability of the remaining parts or provisions.
Disclosure of Interest: Liquidity receives commission from dealing in securities and its introducers of business may directly share in this commission. Liquidity and its associates may hold shares in Universal Biosecurity Limited.
